PSMA

You have access
PSMA Ligands for PET Imaging of Prostate Cancer
Sarah M. Schwarzenboeck, Isabel Rauscher, Christina Bluemel, Wolfgang P. Fendler, Steven P. Rowe, Martin G. Pomper, Ali Asfhar-Oromieh, Ken Herrmann and Matthias Eiber

Journal of Nuclear Medicine October 1, 2017, 58 (10) 1545-1552; DOI: https://doi.org/10.2967/jnumed.117.191031
You have access
Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer
James M. Kelly, Alejandro Amor-Coarasa, Anastasia Nikolopoulou, Till Wüstemann, Peter Barelli, Dohyun Kim, Clarence Williams, Xiwei Zheng, Cong Bi, Bao Hu, J. David Warren, David S. Hage, Stephen G. DiMagno and John W. Babich

Journal of Nuclear Medicine September 1, 2017, 58 (9) 1442-1449; DOI: https://doi.org/10.2967/jnumed.116.188722
You have access
Clinical History of the Theranostic Radionuclide Approach to Neuroendocrine Tumors and Other Types of Cancer: Historical Review Based on an Interview of Eric P. Krenning by Rachel Levine
Rachel Levine and Eric P. Krenning

Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 3S-9S; DOI: https://doi.org/10.2967/jnumed.116.186502
You have access
¹⁷⁷Lu-PSMA Radioligand Therapy for Prostate Cancer
Wolfgang P. Fendler, Kambiz Rahbar, Ken Herrmann, Clemens Kratochwil and Matthias Eiber

Journal of Nuclear Medicine August 1, 2017, 58 (8) 1196-1200; DOI: https://doi.org/10.2967/jnumed.117.191023
You have access
The Clinical Impact of Additional Late PET/CT Imaging with ⁶⁸Ga-PSMA-11 (HBED-CC) in the Diagnosis of Prostate Cancer
Ali Afshar-Oromieh, Lars Peter Sattler, Walter Mier, Boris A. Hadaschik, Jürgen Debus, Tim Holland-Letz, Klaus Kopka and Uwe Haberkorn

Journal of Nuclear Medicine May 1, 2017, 58 (5) 750-755; DOI: https://doi.org/10.2967/jnumed.116.183483
You have access
Preclinical Evaluation of ¹⁸F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer Imaging
Jens Cardinale, Martin Schäfer, Martina Benešová, Ulrike Bauder-Wüst, Karin Leotta, Matthias Eder, Oliver C. Neels, Uwe Haberkorn, Frederik L. Giesel and Klaus Kopka

Journal of Nuclear Medicine March 1, 2017, 58 (3) 425-431; DOI: https://doi.org/10.2967/jnumed.116.181768
You have access
Optimization of Labeling PSMA^HBED with Ethanol-Postprocessed ⁶⁸Ga and Its Quality Control Systems
Elisabeth Eppard, Tatjana Homann, Ana de la Fuente, Markus Essler and Frank Rösch

Journal of Nuclear Medicine March 1, 2017, 58 (3) 432-437; DOI: https://doi.org/10.2967/jnumed.116.177634
You have access
⁶⁸Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with ²²³Ra: Proof of Concept
Hojjat Ahmadzadehfar, Kambiz Azgomi, Stefan Hauser, Xiao Wei, Anna Yordanova, Florian C. Gaertner, Stefan Kürpig, Holger Strunk and Markus Essler

Journal of Nuclear Medicine March 1, 2017, 58 (3) 438-444; DOI: https://doi.org/10.2967/jnumed.116.178533
You have access
Preclinical Evaluation and First Patient Application of ^99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer
Stephanie Robu, Margret Schottelius, Matthias Eiber, Tobias Maurer, Jürgen Gschwend, Markus Schwaiger and Hans-Jürgen Wester

Journal of Nuclear Medicine February 1, 2017, 58 (2) 235-242; DOI: https://doi.org/10.2967/jnumed.116.178939
You have access
Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with ¹⁷⁷Lu-PSMA-617
Justin Ferdinandus, Elisabeth Eppard, Florian C. Gaertner, Stefan Kürpig, Rolf Fimmers, Anna Yordanova, Stefan Hauser, Georg Feldmann, Markus Essler and Hojjat Ahmadzadehfar

Journal of Nuclear Medicine February 1, 2017, 58 (2) 312-319; DOI: https://doi.org/10.2967/jnumed.116.178228

Main menu

User menu

Search

PSMA

Pages